Chem. J. Chinese Universities ›› 1999, Vol. 20 ›› Issue (7): 1021.

• Articles • Previous Articles     Next Articles

The Luminescence of Eu2+in Mixed Phase System

LIU Ying-Liang1, FENG De-Xiong1, YANG Pei-Hui1, SHI Qing-shan2   

  1. 1. Department of Chemistry, Jinan University, Guangzhou, 510632;
    2. Laboratory of Rare Earth Chemistry and Physics, Chang chun Institute of Applied Chemistry, Chinese Acadamy of Sciences, Chang chun, 130022
  • Received:1998-08-18 Online:1999-07-24 Published:1999-07-24

Abstract: The dependence of the structure of the hosts on the Mion radius in MMgAl10O17(M=Be, Mg, Ca, Sr, Ba, Pb, Eu, Mn, Fe, Co, Ni, Zn, Cd, Sn) system was studied and the luminescence of Eu2+in the mixed phase system was discussed. When Mion radius is less than 0.10nm, the system MMgAl10O17constructs by the mixed phases consisting of manegtoplumbite and spinel, α-alumina or spinel and α-alumina. In the mixed phase of manegtoplumbite and spinel and α-alumina, Eu2+ion preferentially occupies lattice site of the cations in manegtoplumbite well matched with the radius and charge of Eu2+. There exists only d→f transition emission of Eu2+and no characteristic emission of Eu3+occurs in those hosts. In the mixed phase of spinel and α alumina, Eu2+can enter the lattice site of Mg2+ion or Al 3+ion and the d→f and f→f transition of Eu2+can been observed respectively. Mean-while, since the radius and charge of matrix lattice ions substituted by Eu2+do not match with those of Eu2+, the valence state of Eu2+is unstable. Eu2+is partly changed into Eu3+and the emission of Eu3+is obviously observed even under the condition of reduction atmosphere. If reaction temperature is more than1150 ℃, Al2O3forms α-Al2O3structure, the f→f transition of Eu2+appears. If reaction temperature is less than1150 ℃, a mixed phase of α-Al2O3and γ-Al2O3is formed, the f→f transition of Eu2+disappears and a new band emission from d→f transition of Eu2+occurs.

Key words: Europium, Mixed phase system, Luminescence, Valence state stability

CLC Number: 

TrendMD: